AVAI
Atlas Venture Associates IX Portfolio holdings
AUM
$11.8M
This Quarter Return
-16.3%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
–
AUM
$47.3M
AUM Growth
+$47.3M
(-18%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 96.23% |
| 2 | Communication Services | 3.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Intellia Therapeutics
NTLA
$1.22B
| $19.8M | 41.77% | 1,615,321 | – | – |
|
2
Spero Therapeutics
SPRO
$116M
| $11.1M | 23.53% | 1,376,968 | – | – |
|
|
SURF
3
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $8.69M | 18.37% | 4,645,453 | – | – |
|
4
Synlogic
SYBX
$17M
| $4.56M | 9.64% | 2,651,963 | – | – |
|
5
Snap
SNAP
$12.1B
| $1.79M | 3.77% | 150,160 | – | – |
|
6
Cogent Biosciences
COGT
$1.69B
| $1.38M | 2.91% | 3,361,535 | – | – |
|